Related Experiment Video

Updated: Aug 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Mild cognitive impairment: A review of the literature]

A K Hödl1, R M Bonelli, H P Kapfhammer

  • 1Universitätsklinik für Psychiatrie, Medizinische Universität Graz.

MMW Fortschritte Der Medizin
|June 29, 2005
PubMed

Insights

Mild cognitive impairment (MCI) involves memory and attention deficits but isn't dementia. Early diagnosis and treatment of MCI can help delay the progression to Alzheimer's disease.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Context:

  • Mild cognitive impairment (MCI) is characterized by moderate memory loss and cognitive deficits, distinct from dementia.
  • Individuals with MCI experience forgetfulness impacting daily life, work, and family relationships.
  • A significant percentage of MCI cases (10-15% annually) progress to Alzheimer's disease.

Purpose:

  • To highlight the importance of early diagnosis and treatment for mild cognitive impairment (MCI).
  • To discuss diagnostic methods and therapeutic strategies for MCI.
  • To emphasize the potential to delay Alzheimer's disease progression through timely intervention.

Summary:

  • MCI presents with memory impairment and cognitive flexibility deficits, not meeting dementia criteria.
  • Diagnostic tools for MCI include cerebrospinal fluid biomarkers, neuroimaging, and neuropsychological testing.
  • Neuropsychological testing can detect deficits even before neuroimaging abnormalities appear.
  • Therapies for MCI mirror Alzheimer's disease treatments, including cholinesterase-inhibitors, antioxidants, and psychological support.

Impact:

  • Early detection and intervention in MCI can potentially slow the transition to Alzheimer's disease.
  • Understanding MCI's progression is crucial for developing effective management strategies.
  • Timely treatment may improve quality of life for individuals with MCI and their families.

More Related Videos

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement10:37

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...